Coeptis Therapeutics Inc.
COEP | NASDAQ
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.58M | 113.77K | 862.05K | 237.44K | 200.68K | 62.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K |
Cost of Revenue | 2.19M | 45.16K | 45.16K | 45.16K | 45.16K | 45.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -608.44K | 68.62K | 816.89K | 192.29K | 155.52K | 17.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K |
Operating Income | -13.79M | -3.91M | -1.99M | -2.48M | -4.52M | -4.06M | -2.16M | -2.14M | -2.83M | -2.92M | -3.54M | -7.9M | -3.68M | -6.54M | -3.04M | -5.57M | -9.81M | -15.72M | -2.96M | -6.95M | -2.62M | -1.7M |
Interest Income | n/a | n/a | 116.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.92K | n/a | n/a | n/a |
Pretax Income | -13.79M | -4.02M | -1.62M | -2.9M | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M | -3M | -4.02M | -6.35M | -3.2M | -7.96M | -2.94M | -5.65M | -9.8M | -19.18M | -2.84M | -5.95M | -2.71M | -1.95M |
Net Income | -13.72M | -4.02M | -1.58M | -2.74M | -3.53M | -3.06M | -1.95M | -1.73M | -3.04M | -3M | -4.02M | -6.35M | -3.2M | -7.96M | -2.94M | -5.65M | -9.8M | -19.18M | -2.84M | -5.95M | -2.71M | -1.95M |
Selling & General & Admin | 26.62K | 644.7K | 2.24M | 1.83M | 4.14M | 3.74M | 1.57M | 1.08M | 2.18M | 1.9M | 2.35M | 2.58M | 2.97M | 6.17M | 3.22M | 5.49M | 9.75M | 15.72M | 3.04M | 6.76M | 2.58M | 1.74M |
Research & Development | n/a | 235.53K | 312.9K | 587.28K | 290.31K | 86.66K | 343.88K | 811.78K | 398.82K | 777.07K | 1.28M | 5.07M | 466.63K | 115.33K | n/a | 20.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 3.1M | 250K | 250K | 250K | 250K | 250K | 250K | 250K | 250K | -93.85K | 250K | 250K | 250K | -176.07K | 56.42K | 63.83K | n/a | -79.25K | 188.56K | 43.1K | 34.74K |
Operating Expenses | 26.62K | 3.98M | 2.81M | 2.67M | 4.68M | 4.07M | 2.16M | 2.14M | 2.83M | 2.92M | 3.54M | 7.9M | 3.68M | 6.54M | 3.04M | 5.57M | 9.81M | 15.72M | 2.96M | 6.95M | 2.62M | 1.78M |
Interest Expense | -226 | 5.26K | 440.49K | 62.61K | 67.79K | 71.49K | 78.63K | 50.93K | 66.06K | 200.51K | 13.83K | 19.8K | 42.64K | 31.42K | 42.34K | 56.42K | 63.83K | 55.82K | -77.33K | 188.56K | 43.1K | 34.74K |
Selling & Marketing Expenses | 9.74K | n/a | n/a | n/a | n/a | 106.5K | -5K | n/a | 5K | n/a | n/a | 12.41K | 300 | n/a | 1.42K | 2.86K | 4.05K | n/a | n/a | n/a | n/a | 2.92K |
Cost & Expenses | 2.22M | 4.03M | 2.85M | 2.71M | 4.72M | 4.12M | 2.16M | 2.14M | 2.83M | 2.92M | 3.54M | 7.9M | 3.68M | 6.54M | 3.04M | 5.57M | 9.81M | 15.72M | 2.96M | 6.95M | 2.62M | 1.78M |
Income Tax Expense | -72.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 49.76M | 6.03M | 4.23M | 4.75M | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 19.52M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
Shares Outstanding (Diluted) | 49.76M | 6.03M | 4.23M | 4.75M | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 20.44M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
EPS (Basic) | -0.28 | -0.65 | -0.29 | -0.58 | -0.95 | -0.99 | -1.01 | -0.05 | -0.08 | -0.08 | -0.11 | -0.23 | -0.14 | -0.46 | -0.20 | -0.29 | -0.48 | -166.75K | -0.30 | -0.29 | -0.13 | -0.10 |
EPS (Diluted) | -0.28 | -0.65 | -0.29 | -0.58 | -0.95 | -0.99 | -1.01 | -0.05 | -0.08 | -0.08 | -0.11 | -0.23 | -0.14 | -0.46 | -0.20 | -0.28 | -0.48 | -166.75K | -0.30 | -0.29 | -0.13 | -0.10 |
EBITDA | -13.79M | -3.51M | -876.4K | -2.53M | -3.96M | -3.04M | -2.67M | -1.5M | -2.72M | -2.54M | -3.76M | -6.05M | -2.91M | -7.68M | -2.65M | -5.34M | -9.49M | -18.87M | -2.47M | -5.76M | -2.67M | -1.91M |
EBIT | n/a | -3.76M | -1.18M | -2.84M | -4.27M | -3.35M | -2.93M | -1.78M | -2.97M | -2.8M | -4.01M | -6.33M | -3.16M | -7.93M | -2.9M | -5.59M | -9.74M | -19.12M | -2.92M | -5.76M | -2.67M | -1.92M |
Depreciation & Amortization | n/a | 250K | 306.01K | 305.77K | 305.53K | 305.3K | 259.98K | 278.23K | 250K | 259.34K | 250.31K | 280.55K | 250.31K | 250.31K | 250.35K | 250.35K | 250.35K | 250.35K | 446.2K | 366 | 367 | 481 |
Add to Watchlist
Select watchlists to add or remove COEP